9-96235528-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000197.2(HSD17B3):c.865G>A(p.Gly289Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0618 in 1,613,652 control chromosomes in the GnomAD database, including 4,380 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G289C) has been classified as Likely benign.
Frequency
Consequence
NM_000197.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HSD17B3 | NM_000197.2 | c.865G>A | p.Gly289Ser | missense_variant | 11/11 | ENST00000375263.8 | |
SLC35D2-HSD17B3 | NR_182427.1 | n.3632G>A | non_coding_transcript_exon_variant | 26/26 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HSD17B3 | ENST00000375263.8 | c.865G>A | p.Gly289Ser | missense_variant | 11/11 | 1 | NM_000197.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0775 AC: 11786AN: 152124Hom.: 653 Cov.: 33
GnomAD3 exomes AF: 0.0724 AC: 18153AN: 250766Hom.: 1034 AF XY: 0.0712 AC XY: 9653AN XY: 135524
GnomAD4 exome AF: 0.0602 AC: 87913AN: 1461410Hom.: 3728 Cov.: 31 AF XY: 0.0607 AC XY: 44142AN XY: 726984
GnomAD4 genome AF: 0.0774 AC: 11788AN: 152242Hom.: 652 Cov.: 33 AF XY: 0.0778 AC XY: 5794AN XY: 74428
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 04, 2019 | This variant is associated with the following publications: (PMID: 29998616, 28859874, 19214745, 9709959, 25605705, 12210481, 23139742, 20059664, 23295294) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Testosterone 17-beta-dehydrogenase deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 06, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at